Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
34.7M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
10M
-
Shares change
-
+10M
-
Total reported value, excl. options
-
$178M
-
Value change
-
+$178M
-
Number of buys
-
33
-
Price
-
$17.75
Significant Holders of IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) as of Q3 2019
33 filings reported holding IGMS - IGM Biosciences, Inc. - Common Stock, par value $0.01 per share as of Q3 2019.
IGM Biosciences, Inc. - Common Stock, par value $0.01 per share (IGMS) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10M shares
of 34.7M outstanding shares and own 28.9% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (3.14M shares), BAKER BROS. ADVISORS LP (3.14M shares), PRICE T ROWE ASSOCIATES INC /MD/ (815K shares), JANUS HENDERSON GROUP PLC (527K shares), RA CAPITAL MANAGEMENT, L.P. (466K shares), HILLHOUSE CAPITAL ADVISORS, LTD. (350K shares), MILLENNIUM MANAGEMENT LLC (254K shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (250K shares), Artal Group S.A. (200K shares), and Cormorant Asset Management, LP (156K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.